T2	eligibility 337 450	women with early stage invasive breast cancer at high risk of recurrence because of metabolic or endocrine milieu
T4	total-participants 639 643	1208
T5	control 708 724	comparison group
T6	age 1552 1562	51.8 years
T8	outcome 1850 1882	reduce breast cancer recurrences
T9	intervention 659 686	intensive diet and exercise
